Genome-wide association analyses suggest NELL1 influences adverse metabolic response to HCTZ in African Americans

Hydrochlorothiazide (HCTZ) is one of the most widely prescribed antihypertensive medications. Although it is well known that HCTZ is associated with hyperglycemia and hypertriglyceridemia, the mechanisms underlying these adverse effects are not well understood. We performed a genome-wide association...

Full description

Bibliographic Details
Main Authors: Del-Aguila, J L, Beitelshees, A L, Cooper-DeHoff, R M, Chapman, A B, Gums, J G, Bailey, K, Gong, Y, Turner, S T, Johnson, J A, Boerwinkle, E
Format: Online
Language:English
Published: Nature Publishing Group 2014
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3812324/
id pubmed-3812324
recordtype oai_dc
spelling pubmed-38123242014-03-20 Genome-wide association analyses suggest NELL1 influences adverse metabolic response to HCTZ in African Americans Del-Aguila, J L Beitelshees, A L Cooper-DeHoff, R M Chapman, A B Gums, J G Bailey, K Gong, Y Turner, S T Johnson, J A Boerwinkle, E Original Article Hydrochlorothiazide (HCTZ) is one of the most widely prescribed antihypertensive medications. Although it is well known that HCTZ is associated with hyperglycemia and hypertriglyceridemia, the mechanisms underlying these adverse effects are not well understood. We performed a genome-wide association study and meta-analysis of the change in fasting plasma glucose and triglycerides in response to HCTZ from two different clinical trials: the Pharmacogenomic Evaluation of Antihypertensive Responses and the Genetic Epidemiology of Responses to Antihypertensive studies. Two single-nucleotide polymorphisms (rs12279250 and rs4319515 (r2=0.73)), located at 11p15.1 in the NELL1 gene, achieved genome-wide significance for association with change in fasting plasma triglycerides in African Americans, whereby each variant allele was associated with a 28 mg dl−1 increase in the change in triglycerides. NELL1 encodes a cytoplasmic protein that contains epidermal growth factor-like repeats and has been shown to represses adipogenic differentiation. These findings may represent a novel mechanism underlying HCTZ-induced adverse metabolic effects. Nature Publishing Group 2014-02 2013-02-12 /pmc/articles/PMC3812324/ /pubmed/23400010 http://dx.doi.org/10.1038/tpj.2013.3 Text en Copyright © 2014 Macmillan Publishers Limited http://creativecommons.org/licenses/by-nc-nd/3.0/ This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivs 3.0 Unported License. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/
repository_type Open Access Journal
institution_category Foreign Institution
institution US National Center for Biotechnology Information
building NCBI PubMed
collection Online Access
language English
format Online
author Del-Aguila, J L
Beitelshees, A L
Cooper-DeHoff, R M
Chapman, A B
Gums, J G
Bailey, K
Gong, Y
Turner, S T
Johnson, J A
Boerwinkle, E
spellingShingle Del-Aguila, J L
Beitelshees, A L
Cooper-DeHoff, R M
Chapman, A B
Gums, J G
Bailey, K
Gong, Y
Turner, S T
Johnson, J A
Boerwinkle, E
Genome-wide association analyses suggest NELL1 influences adverse metabolic response to HCTZ in African Americans
author_facet Del-Aguila, J L
Beitelshees, A L
Cooper-DeHoff, R M
Chapman, A B
Gums, J G
Bailey, K
Gong, Y
Turner, S T
Johnson, J A
Boerwinkle, E
author_sort Del-Aguila, J L
title Genome-wide association analyses suggest NELL1 influences adverse metabolic response to HCTZ in African Americans
title_short Genome-wide association analyses suggest NELL1 influences adverse metabolic response to HCTZ in African Americans
title_full Genome-wide association analyses suggest NELL1 influences adverse metabolic response to HCTZ in African Americans
title_fullStr Genome-wide association analyses suggest NELL1 influences adverse metabolic response to HCTZ in African Americans
title_full_unstemmed Genome-wide association analyses suggest NELL1 influences adverse metabolic response to HCTZ in African Americans
title_sort genome-wide association analyses suggest nell1 influences adverse metabolic response to hctz in african americans
description Hydrochlorothiazide (HCTZ) is one of the most widely prescribed antihypertensive medications. Although it is well known that HCTZ is associated with hyperglycemia and hypertriglyceridemia, the mechanisms underlying these adverse effects are not well understood. We performed a genome-wide association study and meta-analysis of the change in fasting plasma glucose and triglycerides in response to HCTZ from two different clinical trials: the Pharmacogenomic Evaluation of Antihypertensive Responses and the Genetic Epidemiology of Responses to Antihypertensive studies. Two single-nucleotide polymorphisms (rs12279250 and rs4319515 (r2=0.73)), located at 11p15.1 in the NELL1 gene, achieved genome-wide significance for association with change in fasting plasma triglycerides in African Americans, whereby each variant allele was associated with a 28 mg dl−1 increase in the change in triglycerides. NELL1 encodes a cytoplasmic protein that contains epidermal growth factor-like repeats and has been shown to represses adipogenic differentiation. These findings may represent a novel mechanism underlying HCTZ-induced adverse metabolic effects.
publisher Nature Publishing Group
publishDate 2014
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3812324/
_version_ 1612021693194174464